Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Masked, Parallel Group, Multicenter, Study To Evaluate Efficacy And Safety of SDN -037 Twice Daily Compared With Vehicle For The Treatment Of Inflammation And Pain Associated With Ocular Surgery.
Conditions
Interventions
SDN-037
Placebo
Locations
19
United States
SPARC Site 13
Chandler, Arizona, United States
SPARC Site 14
Mesa, Arizona, United States
SPARC Site 11
Prescott, Arizona, United States
SPARC Site 12
Sun City, Arizona, United States
SPARC site 01
Fayetteville, Arkansas, United States
SPARC Site 10
Santa Barbara, California, United States
Start Date
September 28, 2018
Primary Completion Date
March 5, 2020
Completion Date
March 5, 2020
Last Updated
May 17, 2021
Lead Sponsor
Sun Pharma Advanced Research Company Limited
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions